Autologous HSC Transplant in T-MDS/Aml Using Cells Harvested Prior to the Development of the Secondary Malignancy

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.194
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

AML Cells Block HSC Differentiation

Cancer Discovery
Oncology
2013English

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2014English

Physicians Poster Session: Acute Leukemia and Secondary AML/MDS

Bone Marrow Transplantation
TransplantationHematology
2003English

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

From MDS/AML to iPSC and Back Again

Science Translational Medicine
Medicine
2017English

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Molecular Characterization of Chromosome 7 in AML and MDS Patients

African Journal of Health Sciences
2008English

Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant

Bone Marrow Transplantation
TransplantationHematology
2018English

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy